首页> 外文期刊>EJVES Short Reports >Interventional Management of In-stent Thrombosis after Superior Mesenteric Vein stenting
【24h】

Interventional Management of In-stent Thrombosis after Superior Mesenteric Vein stenting

机译:高级肠系膜静脉支架后支架血栓形成的介入治疗

获取原文
           

摘要

Introduction: Mesenteric vein stenosis and thrombosis are rare conditions, without a definite treatment strategy. Report: A 46 year-old man underwent pancreatic resection with a polytetrafluoroethylene (PTFE) graft vascular reconstruction; he subsequently developed anastomotic mesenteric vein stenosis, which was treated with transhepatic venoplasty and stenting. Three months later, he suffered an in-stent thrombosis, after a reduction in heparin dosage. The thrombosis was successfully managed, after a failed systemic thrombolysis, with a direct thrombolysis via transjugular approach. At 10 months’ follow-up, the stent was still patent. Conclusion: Mesenteric vein stenting is effective on PTFE grafts, but appropriate anticoagula- tion is helpful to avoid subsequent in-stent thrombosis.
机译:简介:肠系膜静脉狭窄和血栓形成是罕见的条件,没有明确的治疗策略。报告:一名46岁男子经历胰腺切除胰腺切除,具有聚四氟乙烯(PTFE)移植物血管重建;他随后开发了吻合体肠系膜静脉狭窄,用经胸腺成形术和支架进行了处理。三个月后,他在减少肝素剂量后遭受了血栓形成的血栓形成。在失败的全身溶栓后,血栓形成成功管理,通过讲台方法直接溶栓。在10个月的后续后,支架仍然是专利。结论:肠系膜静脉支架对PTFE移植物有效,但适当的抗衡凝固有助于避免随后的血栓形成。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号